NANT TNBC Vaccine NantKwest, Inc. Clinical Trial Protocol: QUILT -3.067 NANT TRIPLE NEGATIVE BREAST CANCER (TNBC) VACCINE: MOLECULARLY INFORMED INTEGRATED IMMUNOTHERAPY COMBINING INNATE HIGH -AFFINITY NATURAL KIL LER (ha NK) CELL THERAPY WITH ADAPTIVE T -CELL THERAPY (ADENOVIRUS, YEAST, FUSION PROTEIN VACCI NE) IN SUBJECTS WITH TNBC WHO HAVE PROGRESSED ON OR AFTER STANDARD -OF-CARE THERAPY Study Number: QUILT -3.067 IND Sponsor: NantKwest, Inc. 9920 Jefferson Blvd Culver City, CA 90232 Sponsor Contact: (For medical questions/emergencies) John H.